Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl Peck

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Annual Review of Pharmacology and Toxicology|September 22, 2010
Physiologically-based pharmacokinetics in drug development and regulatory scienceMalcolm Rowland, Carl Peck, Geoffrey Tucker
AAPS Pharmsci|June 17, 2004
Physiologically based pharmacokinetics in drug development and regulatory science: a workshop report (Georgetown University, Washington, DC, May 29-30, 2002)Malcolm Rowland, Luc Balant, Carl Peck
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 2, 2007
Current issues relating to drug safety especially with regard to the use of biomarkers: a meeting report and progress updatePaul Rolan, Meindert Danhof, Donald Stanski, et al.
Nature Immunology|August 8, 2019
Author Correction: At the end of the beginning: immunotherapies as living drugsEllen G Feigal, Natalie D DeWitt, Cathy Cantilena, et al.
The AAPS Journal|September 1, 2022
Comparing a Bayesian Approach (BEST) with the Two One-Sided t-Tests (TOSTs) for Bioequivalence StudiesCarl Peck, Gregory Campbell, Isaac Yoo, et al.
Pharmacoepidemiology and Drug Safety|November 13, 2002
Postmarketing drug dosage changes of 499 FDA-approved new molecular entities, 1980-1999James Cross, Howard Lee, Agnes Westelinck, et al.
Nature Immunology|July 17, 2019
At the end of the beginning: immunotherapies as living drugsEllen G Feigal, Natalie D DeWitt, Cathy Cantilena, et al.
The Journal of Surgical Research|August 3, 2014
17α-Ethynylestradiol-3-sulfate treatment of severe blood loss in ratsWilliam Hubbard, James Keith, Jonathan Berman, et al.
The Journal of Trauma and Acute Care Surgery|May 24, 2014
Efficacy of 17α-ethynylestradiol-3-sulfate for severe hemorrhage in minipigs in the absence of fluid resuscitationMatthew Miller, James Keith, Jonathan Berman, et al.
The AAPS Journal|February 27, 2024
The Role of Model Master Files for Sharing, Acceptance, and Communication with FDALanyan Fang, Yuqing Gong, Andrew C Hooker, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Annual Review of Pharmacology and Toxicology|September 22, 2010
Physiologically-based pharmacokinetics in drug development and regulatory scienceMalcolm Rowland, Carl Peck, Geoffrey Tucker
AAPS Pharmsci|June 17, 2004
Physiologically based pharmacokinetics in drug development and regulatory science: a workshop report (Georgetown University, Washington, DC, May 29-30, 2002)Malcolm Rowland, Luc Balant, Carl Peck
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 2, 2007
Current issues relating to drug safety especially with regard to the use of biomarkers: a meeting report and progress updatePaul Rolan, Meindert Danhof, Donald Stanski, et al.
Nature Immunology|August 8, 2019
Author Correction: At the end of the beginning: immunotherapies as living drugsEllen G Feigal, Natalie D DeWitt, Cathy Cantilena, et al.
The AAPS Journal|September 1, 2022
Comparing a Bayesian Approach (BEST) with the Two One-Sided t-Tests (TOSTs) for Bioequivalence StudiesCarl Peck, Gregory Campbell, Isaac Yoo, et al.
Pharmacoepidemiology and Drug Safety|November 13, 2002
Postmarketing drug dosage changes of 499 FDA-approved new molecular entities, 1980-1999James Cross, Howard Lee, Agnes Westelinck, et al.
Nature Immunology|July 17, 2019
At the end of the beginning: immunotherapies as living drugsEllen G Feigal, Natalie D DeWitt, Cathy Cantilena, et al.
The Journal of Surgical Research|August 3, 2014
17α-Ethynylestradiol-3-sulfate treatment of severe blood loss in ratsWilliam Hubbard, James Keith, Jonathan Berman, et al.
The Journal of Trauma and Acute Care Surgery|May 24, 2014
Efficacy of 17α-ethynylestradiol-3-sulfate for severe hemorrhage in minipigs in the absence of fluid resuscitationMatthew Miller, James Keith, Jonathan Berman, et al.
The AAPS Journal|February 27, 2024
The Role of Model Master Files for Sharing, Acceptance, and Communication with FDALanyan Fang, Yuqing Gong, Andrew C Hooker, et al.
Pageof 1